QLSGX | VISGX | QLSGX / VISGX | |
Total Expense Ratio | 0.88 | 0.19 | 463% |
Annual Report Gross Expense Ratio | 1.01 | 0.19 | 532% |
Fund Existence | 9 years | 27 years | - |
Gain YTD | 11.909 | 4.457 | 267% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 522M | 37.5B | 1% |
Annual Yield % from dividends | 0.00 | 0.42 | - |
Returns for 1 year | 15.35 | 13.37 | 115% |
Returns for 3 years | 40.46 | 34.55 | 117% |
Returns for 5 years | 21.36 | 34.38 | 62% |
Returns for 10 years | N/A | 138.28 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
JPMB | 39.73 | 0.22 | +0.57% |
JPMorgan USD Emerging Mkts Svr Bd ETF | |||
IVW | 116.23 | 0.64 | +0.55% |
iShares S&P 500 Growth ETF | |||
XCNY | 26.33 | N/A | N/A |
SPDR S&P Emerging Markets ex-China ETF | |||
FLGB | 31.90 | -0.06 | -0.19% |
Franklin FTSE United Kingdom ETF | |||
PBE | 68.20 | -0.26 | -0.38% |
Invesco Biotechnology & Genome ETF |